Little Green Pharma Ltd (LGP.AX)
AUD 0.12
(-8.0%)
AUD 0.12
(-8.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.04 AUD | 63.2% |
| 2022 | -0.10 AUD | -280.23% |
| 2021 | -0.03 AUD | 59.35% |
| 2020 | -0.06 AUD | -56.28% |
| 2019 | -0.04 AUD | -46.81% |
| 2018 | -0.03 AUD | -1662.5% |
| 2017 | -0.00 AUD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.01 AUD | -100.0% |
| 2024 Q1 | -0.00 AUD | 2.78% |
| 2023 Q2 | -0.03 AUD | -100.0% |
| 2023 FY | - AUD | 63.2% |
| 2023 Q1 | -0.02 AUD | 0.0% |
| 2023 Q4 | -0.00 AUD | -80.0% |
| 2023 Q3 | -0.00 AUD | 93.59% |
| 2022 Q2 | -0.02 AUD | -112.13% |
| 2022 Q1 | 0.15 AUD | 146.31% |
| 2022 FY | - AUD | -280.23% |
| 2022 Q3 | -0.02 AUD | 0.0% |
| 2021 FY | - AUD | 59.35% |
| 2021 Q4 | 0.06 AUD | 1803.13% |
| 2021 Q3 | 0.00 AUD | 131.37% |
| 2021 Q1 | -0.03 AUD | -176.7% |
| 2021 Q2 | -0.01 AUD | 64.21% |
| 2020 FY | - AUD | -56.28% |
| 2020 Q4 | -0.01 AUD | 75.06% |
| 2020 Q3 | -0.04 AUD | -6.99% |
| 2020 Q2 | -0.04 AUD | -62.18% |
| 2020 Q1 | -0.02 AUD | -3.93% |
| 2019 Q3 | -0.02 AUD | -4.14% |
| 2019 Q2 | -0.02 AUD | 0.0% |
| 2019 Q4 | -0.02 AUD | -30.11% |
| 2019 FY | - AUD | -46.81% |
| 2018 FY | - AUD | -1662.5% |
| 2017 FY | - AUD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Althea Group Holdings Limited | -0.09 AUD | 56.858% |
| Cann Group Limited | -0.11 AUD | 66.545% |
| ECS Botanics Holdings Ltd | 0.00 AUD | 2400.0% |
| Ecofibre Limited | -0.12 AUD | 69.333% |
| Elixinol Wellness Limited | -0.01 AUD | -199.187% |
| Hygrovest Limited | -0.00 AUD | -6033.333% |
| IDT Australia Limited | -0.02 AUD | -137.419% |
| Invion Limited | -0.00 AUD | -3988.889% |
| Live Verdure Ltd | -0.11 AUD | 66.545% |
| Medical Developments International Limited | -0.46 AUD | 92.0% |
| Vitura Health Limited | 0.01 AUD | 693.548% |
| Vita Life Sciences Limited | 0.17 AUD | 121.647% |